Beyond Accelerated Approvals: External Control Arms

Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.
Alternatives to randomized control arms have been hotly debated since the emergence of randomized controlled clinical trials (RCT). Historical controls, synthetic controls, and external controls are among the options often discussed. This expert panel reviews the latest FDA guidance and definitions surrounding the different types of external control arms. Cardinal Health Real-World Evidence and Insights share their own methodological approach to generating real-world evidence (RWE) with fit-for-purpose real-world data (RWD), including several case studies of recent research, and highlight the importance of data completeness for external control arms.
For more info, go to: healtheconomic...